Suppr超能文献

全氟碳化合物液体在增殖性玻璃体视网膜病变中的应用:结果与并发症

Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications.

作者信息

Stolba U, Binder S, Velikay M, Datlinger P, Wedrich A

机构信息

University of Vienna, Department of Ophthalmology B, Austria.

出版信息

Br J Ophthalmol. 1995 Dec;79(12):1106-10. doi: 10.1136/bjo.79.12.1106.

Abstract

BACKGROUND

The present study was set up to evaluate the influence of perfluorocarbon liquids on the postoperative anatomical and functional results as well as on the complication rates in eyes with proliferative vitreoretinopathy (PVR).

METHODS

Sixty five consecutive eyes (64 patients) with PVR in different stages requiring surgical intervention where liquid perfluorocarbons were used were compared with 64 consecutive eyes (62 patients) operated without the help of perfluorocarbon immediately before this time. Both groups were similar with regard to severity of PVR, number of operations, and initial visual acuity. The observation period was shorter in the perfluorocarbon group because they were operated more recently (17.4 months as against 24.4 months).

RESULTS

The anatomical as well as the functional success rates were not significantly higher in the perfluorocarbon group (69% v 61% and 65% v 53% respectively). However, in cases operated on without perfluorocarbons where reproliferation would occur it was of much greater severity than in cases where perfluorocarbons were used. The number of uncured cases with contraction of the retina at least in the inferior half was more than twice as high in the group operated on without perfluorocarbon. Combined with massive reproliferation secondary glaucoma and bullous or band keratopathy were more frequent in eyes treated before the use of perfluorocarbon.

CONCLUSION

The intraoperative use of perfluorocarbon liquids in vitreoretinal surgery does not prevent postoperative reproliferation but does reduce its severity.

摘要

背景

本研究旨在评估全氟碳液体对增生性玻璃体视网膜病变(PVR)患眼术后解剖结构和功能恢复结果以及并发症发生率的影响。

方法

将连续65只(64例患者)处于不同阶段、需要手术干预且术中使用了全氟碳液体的PVR患眼,与在此之前连续64只(62例患者)未借助全氟碳液体进行手术的患眼进行比较。两组在PVR严重程度、手术次数和初始视力方面相似。全氟碳液体组的观察期较短,因为他们手术时间更近(分别为17.4个月和24.4个月)。

结果

全氟碳液体组的解剖学和功能成功率并无显著更高(分别为69%对61%和65%对53%)。然而,在未使用全氟碳液体进行手术且会发生再增殖的病例中,其严重程度远高于使用全氟碳液体的病例。在未使用全氟碳液体进行手术的组中,至少视网膜下半部出现收缩的未治愈病例数量高出一倍多。再增殖合并大量新生血管形成时,继发性青光眼以及大泡性或带状角膜病变在使用全氟碳液体之前治疗的患眼中更为常见。

结论

玻璃体视网膜手术中使用全氟碳液体不能防止术后再增殖,但可降低其严重程度。

相似文献

2
Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.
Ophthalmology. 2000 Jun;107(6):1078-82. doi: 10.1016/s0161-6420(00)00095-6.

本文引用的文献

4
Low viscosity liquid fluorochemicals in vitreous surgery.玻璃体手术中的低粘度液态含氟化合物
Am J Ophthalmol. 1987 Jan 15;103(1):38-43. doi: 10.1016/s0002-9394(14)74166-2.
5
Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy.
Am J Ophthalmol. 1987 Jan 15;103(1):24-8. doi: 10.1016/s0002-9394(14)74164-9.
7
The question of ocular tolerance to intravitreal liquid silicone. A long-term analysis.
Ophthalmology. 1986 May;93(5):651-60. doi: 10.1016/s0161-6420(86)33685-6.
8
Silicone oil for advanced proliferative vitreoretinopathy.
Ophthalmology. 1986 May;93(5):646-50. doi: 10.1016/s0161-6420(86)33686-8.
9
Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments.
Am J Ophthalmol. 1987 Dec 15;104(6):624-33. doi: 10.1016/0002-9394(87)90176-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验